secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2022-12-30T23:59:59+00:00
Accession:  0001564590-22-040087
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TRACON receives Nasdaq notice for market value below $35M; 180-day cure period
------------------------------------------------------------------------------

- On Dec 30, 2022, Nasdaq notified TRACON that its common stock market value was below $35M for 30 consecutive business days.
- Company has until June 28, 2023 to regain compliance by having market value >=$35M for 10 consecutive business days.
- Alternative compliance: stockholders' equity >=$2.5M or net income from continuing operations of $500,000 in most recent fiscal year.
- Failure may result in delisting; company evaluating potential actions to regain compliance but no assurance.
- TCON continues trading on Nasdaq during grace period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000156459022040087/0001564590-22-040087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000156459022040087/tcon-8k_20221230.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-040087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer